These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 25239462)
1. Integration of the blaNDM-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate. Girlich D; Dortet L; Poirel L; Nordmann P J Antimicrob Chemother; 2015 Jan; 70(1):98-102. PubMed ID: 25239462 [TBL] [Abstract][Full Text] [Related]
2. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13. Schultz E; Haenni M; Mereghetti L; Siebor E; Neuwirth C; Madec JY; Cloeckaert A; Doublet B J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582 [TBL] [Abstract][Full Text] [Related]
3. Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates. Siebor E; Neuwirth C J Antimicrob Chemother; 2014 Dec; 69(12):3216-20. PubMed ID: 25114166 [TBL] [Abstract][Full Text] [Related]
4. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region. Siebor E; Neuwirth C J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670 [TBL] [Abstract][Full Text] [Related]
5. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region. Ahmed AM; Hussein AI; Shimamoto T J Antimicrob Chemother; 2007 Feb; 59(2):184-90. PubMed ID: 17114173 [TBL] [Abstract][Full Text] [Related]
6. European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O. Doublet B; Poirel L; Praud K; Nordmann P; Cloeckaert A J Antimicrob Chemother; 2010 Oct; 65(10):2260-2. PubMed ID: 20682564 [No Abstract] [Full Text] [Related]
7. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France. Siebor E; Neuwirth C J Antimicrob Chemother; 2013 Aug; 68(8):1750-6. PubMed ID: 23580563 [TBL] [Abstract][Full Text] [Related]
8. Two new Salmonella genomic islands 1 from Proteus mirabilis and description of blaCTX-M-15 on a variant (SGI1-K7). de Curraize C; Neuwirth C; Bador J; Chapuis A; Amoureux L; Siebor E J Antimicrob Chemother; 2018 Jul; 73(7):1804-1807. PubMed ID: 29659873 [TBL] [Abstract][Full Text] [Related]
9. Mobilization of the Salmonella genomic island SGI1 and the Proteus genomic island PGI1 by the A/C2 plasmid carrying blaTEM-24 harboured by various clinical species of Enterobacteriaceae. Siebor E; de Curraize C; Amoureux L; Neuwirth C J Antimicrob Chemother; 2016 Aug; 71(8):2167-70. PubMed ID: 27150396 [TBL] [Abstract][Full Text] [Related]
10. New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China. Bi S; Yan H; Chen M; Zhang Z; Shi L; Wang H J Antimicrob Chemother; 2011 May; 66(5):1178-9. PubMed ID: 21393148 [No Abstract] [Full Text] [Related]
11. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate. Girlich D; Bonnin RA; Bogaerts P; De Laveleye M; Huang DT; Dortet L; Glaser P; Glupczynski Y; Naas T Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855079 [TBL] [Abstract][Full Text] [Related]
12. Genomic context of resistance genes within a French clinical MDR Proteus mirabilis: identification of the novel genomic resistance island GIPmi1. Siebor E; de Curraize C; Neuwirth C J Antimicrob Chemother; 2018 Jul; 73(7):1808-1811. PubMed ID: 29669108 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the Genetic Environment of the bla Espinal P; Miró E; Ramoneda L; Flores M; Rivera A; Coll P; Navarro F Microb Drug Resist; 2017 Oct; 23(7):833-837. PubMed ID: 28304213 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis. Mata C; Navarro F; Miró E; Walsh TR; Mirelis B; Toleman M J Antimicrob Chemother; 2011 Oct; 66(10):2266-70. PubMed ID: 21752830 [TBL] [Abstract][Full Text] [Related]
15. Increased Resistance to Carbapenems in Bontron S; Poirel L; Kieffer N; Savov E; Trifonova A; Todorova I; Kueffer G; Nordmann P Microb Drug Resist; 2019 Jun; 25(5):663-667. PubMed ID: 30676261 [No Abstract] [Full Text] [Related]
16. Genetic characteristics of chromosomally integrated carbapenemase gene (bla Wang Q; Dong K; Liu X; Li W; Bian Q BMC Microbiol; 2024 Jun; 24(1):216. PubMed ID: 38890647 [TBL] [Abstract][Full Text] [Related]
18. Genomic characterisation of a Proteus mirabilis clinical isolate from China carrying bla Sun L; Xu J; He F J Glob Antimicrob Resist; 2019 Dec; 19():317-319. PubMed ID: 31698108 [TBL] [Abstract][Full Text] [Related]
19. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression. Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005 [TBL] [Abstract][Full Text] [Related]
20. Molecular Characterization of Sung JY; Kim S; Kwon G; Koo SH J Microbiol Biotechnol; 2017 Nov; 27(11):2052-2059. PubMed ID: 29032652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]